IUPAC name
N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
SMILES
CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
Compound class
Hypnotics and Sedatives; GABA-A Receptor Agonists; Nervous System; Psycholeptics; Benzodiazepine Related Drugs; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors;
Therapeutic area
For the short-term treatment of insomnia.
Common name
Zolpidem
IUPAC name
N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
SMILES
CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
INCHI
InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3
FORMULA
C19H21N3O
Common name
Zolpidem
IUPAC name
N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
Molecular weight
307.390
clogP
3.352
clogS
-4.768
HBond Acceptor
2
HBond Donor
0
Total Polar Surface Area
37.61
Number of Rings
3
Rotatable Bond
4
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00023 | toluene |
|
c1(ccccc1)C | 0.1268 |
| FDBF00920 | 3,6-dimethylimidazo[1,2-a]pyridine |
|
Cc1n2c(nc1)ccc(c2)C | 0.0003 |
| FDBF00921 | 6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridine |
|
c1(ccc(cc1)C)c2cn3c(n2)ccc(c3)C | 0.0003 |
| FDBF00922 | N,N-dimethylacetamide |
|
CC(=O)N(C)C | 0.0014 |
| FDBF00923 | 3,6-dimethyl-2-(p-tolyl)imidazo[1,2-a]pyridine |
|
c1(ccc(cc1)C)c2c(n3c(n2)ccc(c3)C)C | 0.0003 |
| FDBF00924 | N,N-dimethyl-2-(6-methylimidazo[1,2-a]pyridin-3-yl)acetamide |
|
C(c1n2c(nc1)ccc(c2)C)C(=O)N(C)C | 0.0003 |
| FDBF00925 | N,N-dimethylformamide |
|
O=CN(C)C | 0.0041 |
| FDBF00926 | 6-methylimidazo[1,2-a]pyridine |
|
n12ccnc1ccc(c2)C | 0.0003 |
